Farther Finance Advisors LLC boosted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 31.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 7,661 shares of the pharmacy operator’s stock after purchasing an additional 1,830 shares during the period. Farther Finance Advisors LLC’s holdings in Walgreens Boots Alliance were worth $71,000 at the end of the most recent reporting period.
Several other large investors also recently added to or reduced their stakes in the company. Brooklyn Investment Group grew its holdings in shares of Walgreens Boots Alliance by 21.1% during the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock valued at $44,000 after buying an additional 830 shares in the last quarter. First Financial Corp IN grew its stake in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 885 shares in the last quarter. CWA Asset Management Group LLC increased its holdings in shares of Walgreens Boots Alliance by 9.2% in the 4th quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock valued at $120,000 after purchasing an additional 1,084 shares during the period. Metis Global Partners LLC lifted its position in shares of Walgreens Boots Alliance by 4.9% in the fourth quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator’s stock worth $222,000 after purchasing an additional 1,118 shares in the last quarter. Finally, Crestwood Advisors Group LLC boosted its holdings in shares of Walgreens Boots Alliance by 6.3% during the fourth quarter. Crestwood Advisors Group LLC now owns 20,184 shares of the pharmacy operator’s stock worth $188,000 after purchasing an additional 1,199 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
WBA has been the topic of several research reports. Royal Bank of Canada upped their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Bank of America upped their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research note on Monday, January 13th. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Evercore ISI upped their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Finally, StockNews.com began coverage on Walgreens Boots Alliance in a report on Tuesday, March 18th. They set a “hold” rating for the company. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $10.59.
Walgreens Boots Alliance Stock Down 0.2 %
Shares of Walgreens Boots Alliance stock opened at $11.10 on Friday. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $22.05. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The stock has a 50 day moving average price of $10.96 and a two-hundred day moving average price of $9.83. The stock has a market capitalization of $9.59 billion, a P/E ratio of -1.08, a PEG ratio of 1.31 and a beta of 0.62.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.66 EPS. Equities analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Read More
- Five stocks we like better than Walgreens Boots Alliance
- Best Aerospace Stocks Investing
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- 3 Tickers Leading a Meme Stock Revival
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- ESG Stocks, What Investors Should Know
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.